Transcriptomic and bioinformatic analyses further revealed that AGBL4-realted DEGs were enriched in cancer-associated microRNA-related pathways and IL-17 signaling pathway, the latter being notably related to malignancy in central nervous system tumors. This evidence concerns the gene AGBL4 and cancer.